Company Overview and News

 
Energous Corporation Chosen as a Select Partner to Demonstrate its Award-Winning WattUp Technology at the SK ICT Tech Summit 2018

2018-10-08 globenewswire
SAN JOSE, Calif., Oct. 08, 2018 (GLOBE NEWSWIRE) -- Energous Corporation [NASDAQ: WATT], the developer of WattUp®, a revolutionary wireless charging 2.0 technology, today announced that it was selected by SK Telesys to exclusively demonstrate its award-winning WattUp wireless charging technology at the SK ICT Tech Summit on October 31, 2018.
WATT

86
Akers Biosciences Announces a Leadership Change, Strategic Update, Legal Settlement and an AIM Update

2018-10-08 globenewswire - 8
THOROFARE, N.J., Oct. 08, 2018 (GLOBE NEWSWIRE) -- Akers Biosciences, Inc. (NASDAQ: AKER) (AIM: AKR.L), (“Akers Bio” or the "Company"), a developer of rapid health information technologies, announces a leadership change, an update to the Company’s business strategy, the settlement of its lawsuit with Pulse Health LLC (“Pulse Health”) and the resignation of its Nominated Adviser on the London Stock Exchange’s AIM market.
SSFN AKR PROM PHG LNSTY WATT TE AKER

 
WATT / Energous Corporation null

2018-09-19 sec.gov
begin 644 filename1.pdf M)5!$1BTQ+C4-)>+CS],-"C<@,"!O8FH-/#PO3&EN96%R:7IE9" [email protected],S(P M,#$O3R [email protected],C
WATT

 
WATT / Energous Corporation null

2018-09-19 sec.gov
CORRESP ENERGOUS CORP. 3590 North First Street, Suite 210 San Jose, CA 95134 August 15, 2018 VIA EDGAR
WATT

15
2 Approaches To BioPharma: Interview With TPT Collaborators Amit Ghate And Zach Hartman

2018-09-10 seekingalpha - 4
Thanks for joining us today! Welcome to Dr Zach Hartman and Amit Ghate, two well-known analysts on SeekingAlpha, and very luckily for us here at the Total Pharma Tracker, our two outstanding collaborators.
VTL MNKD TSRO EXEL NVCR GERN XNET TLRY BGNE AERI WATT RDUS

 
Energous Reaches Milestone as it Secures Regulatory Approval for its WattUp Wireless Charging Technology in 100 Countries Worldwide

2018-09-05 globenewswire
As part of its global regulatory campaign, the company reaches a major milestone as WattUp is approved to ship in 100 countries including the U.S., United Kingdom, European Union, Taiwan, India, Australia and Canada
WATT

6
ZAGG: A Steady Change

2018-08-29 seekingalpha
Through organic growth and acquisitions, ZAGG has significant market share in screen protectors, keyboards, power management, power cases, and audio.
SSNLF GOOGL AAPL GOOG BBY ZAGG WATT

 
WATT / Energous Corporation REGISTRATION STATEMENT ON FORM S-3

2018-08-09 sec.gov
Registration Statement on Form S-3 Table of Contents As filed with the Securities and Exchange Commission on August 9, 2018 Registration No. 333-
WATT

 
WATT / Energous Corporation 10-Q (Quarterly Report)

2018-08-09 sec.gov
watt-10q_20180630.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION
WATT

 
Energous Corporation Announces Participation in the Oppenheimer 21st Annual Technology, Internet & Communications Conference

2018-08-06 globenewswire
SAN JOSE, Calif., Aug. 06, 2018 (GLOBE NEWSWIRE) -- Energous Corporation (NASDAQ:WATT), the developer of WattUp®, a revolutionary wire-free, power-at-a-distance charging technology, today announced that Brian Sereda, chief financial officer, will present a company overview at the Oppenheimer 21st Annual Technology, Internet & Communications Conference on Wednesday, Aug. 8, 2018 at 1:45 p.m. ET at the Four Seasons Hotel, in Boston, MA.
WATT

6
Energous (WATT) Reports Q2 Loss, Lags Revenue Estimates

2018-08-01 zacks
Energous (WATT - Free Report) just came out with a quarterly loss of $0.48 per share versus the Zacks Consensus Estimate of a loss of $0.54. This compares to loss of $0.63 per share a year ago. These figures are adjusted for non-recurring items.
BRK.A XOM O OPRF WATT HUBG HUBOF

 
WATT / Energous Corporation 8-K (Current Report)

2018-08-01 sec.gov
watt-8k_20180801.htm UNITED STATES
WATT

213
20 Stocks with Big Short Squeeze Potential | InvestorPlace

2018-07-25 investorplace - 9
There’s a fundamental mathematical proposition that makes shorting stocks risky. A short sale — a sale of borrowed stock, made with the intention of buying it back at a cheaper price later — in theory has unlimited losses. A long investor can only lose 100% of her money at most. But a short could lose multiples of the capital originally at risk.
MDGL FB POSTZ SPWR POSTU SKT NFLX AXDX] HRI SIRI MTCH AMZN SPOT AABA AAPL WATT DIS BGS OSTK RDEN SYNA AMC IAC P AXDX ICPT DLGNF PLCE CAR W REV POST MAT BABA HAS T ATHM POSHZ BITA TSLA VZ AAOI STRP DPZ HTZ TUES PZZA

27
Energous Partners with IDT to Launch WattUp Near Field Wireless Charging 2.0

2018-06-28 globenewswire - 2
Cost-effective, production-ready transmitter solution supports a variety of customer applications including hearing aids, fitness trackers, smartwatches, wireless earbuds and more
WATT 0167

31
Why Apple’s AirPower Wireless Charger Is Taking So Long to Make - Bloomberg

2018-06-22 bloomberg - 6
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
WATT

Related Articles

ALIM: Alimera Sciences Analysis and Research Report

2018-10-01 - Asif

Overview The following discussion and analysis should be read in conjunction with its unaudited interim condensed consolidated financial statements and the related notes that appear elsewhere in this quarterly report on Form 10-Q. This discussion contains forward-looking statements reflecting its current expectations that involve risks and uncertainties. Actual results may differ materially from those discussed in these forward-looking statements due to a number of factors, including those set forth in the section entitled “Risk Factors” in its most recent annual report on Form 10-K. For further information regarding forward-looking statements, please refer to the “Special Note Regarding Forward-Looking Statements and Projections” immediately after the index to this quarterly report on Form 10-Q. Alimera Sciences, Inc., and its subsidiaries (we or Alimera), is a pharmaceutical company that specializes in the commercialization and development of prescription ophthalmic pharma...

DMPI: DelMar Pharmaceuticals Analysis and Research Report

2018-09-25 - Asif

Background DelMar Pharmaceuticals, Inc. is a clinical stage drug development company with a focus on the treatment of cancer. The company's mission is to benefit patients and create shareholder value by developing and commercializing anti-cancer therapies for patients whose tumors exhibit features that make them resistant to, or unlikely to respond to, currently available therapies, particularly for orphan cancer indications where patients have failed, or are unlikely to respond to, currently available therapy. DelMar Pharmaceuticals is developing VAL-083, a novel, DNA-targeting agent, for the treatment of glioblastoma multiforme (“GBM”) and potentially other solid tumors, including ovarian cancer. VAL-083 is a first-in-class, DNA-targeting chemotherapeutic that demonstrated activity against a range of tumor types in prior Phase 1 and Phase 2 clinical studies sponsored by the US National Cancer Institute (“NCI”). The company's recent research has highlighted the opportunit...

RIGL: Rigel Pharmaceuticals Analysis and Research Report

2018-09-18 - Asif

Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...

Silicon Investor Message Boards

This table lists all message boards related to WATT / Energous Corporation on message board site Silicon Investor.

FWGO Fischer-Watt Gold FWGO Fischer-Watt Gold FWGO Fischer-Watt Gold McWatters Mining Inc. (MCW on TSE) McWatters Mining Inc. (MCW on TSE) McWatters Mining Inc. (MCW on TSE)
Wattage Monitor (WMON) Wattage Monitor (WMON) Wattage Monitor (WMON) WMON Wattage Monitor WMON Wattage Monitor WMON Wattage Monitor
Fischer Watt Gold Co.,Inc. - FWGO Fischer Watt Gold Co.,Inc. - FWGO Fischer Watt Gold Co.,Inc. - FWGO
CUSIP: 29272C103